Building Trust And Access For Healthier Latino Communities
Erik Cárdenas co-founded Zócalo Health to increase access to clinical and social care and improve ... More patient experiences for underserved communities.
In this Q&A, Sorenson Impact Institute VC & Impact Investing Senior Associate Hunter Conrad talks with Erik Cárdenas, Co-Founder and CEO of Zócalo Health, to learn how the company leans into community and connection to increase access to clinical and social care and improve patient experiences for underserved communities. The Sorenson Impact Foundation, which invests in innovative impact business models enabling resilience, opportunity, and higher quality of life for low-income populations, invested in Zócalo Health in 2024.
Erik Cárdenas founded Zócalo Health to help address the healthcare needs of Latinos and other underserved populations, and in turn, help build more resilient communities and a stronger economy. As Cárdenas describes, connecting underserved groups with quality healthcare is a foundational step that creates rippling impact: 'When someone gains access to quality care, it doesn't just improve their health; it strengthens the foundation of their household, boosts workforce productivity, and reduces long-term healthcare costs for the system as a whole,' Cárdenas says.
The United States healthcare system faces significant challenges in delivering effective, equitable and accessible care – particularly for low-income communities, people of color, and rural communities. High costs, complex insurance structures, and limited access to primary and preventive care exacerbate disparities, leaving millions underserved or without care altogether–despite the U.S. spending a staggering 18% of GDP on healthcare costs. Because social determinants of health (SDoH) such as housing, education, food access, and transportation are key drivers of health, low-income communities are at elevated risk for poor health outcomes. Zócalo Health's focus on increasing access to quality care by meeting patients where they are in their communities with a holistic care model demonstrated clear alignment with the Sorenson Impact Foundation's investment thesis in the health sector. In addition to the impact for individuals achieved through better health outcomes, a community-based, preventative model such as Zócalo has the potential to reduce reliance on costly, reactive healthcare interventions and more effectively manage chronic conditions, thereby reducing overall costs to the system.
'At a macro level, healthcare equity is a matter of national stability,' Cárdenas says. 'The U.S. Latino population is projected to reach nearly 30% of the total population by 2050. Ensuring that this growing demographic has access to high-quality, culturally competent healthcare isn't just the right thing to do — it's a necessity for the country's economic and social future.'
Zócalo Health aims to make a lasting impact by providing culturally aligned services that build trust between the Latino community and healthcare providers. 'It's not just about logistics — it's about deeply ingrained cultural beliefs that shape how Latinos engage with healthcare,' Cárdenas says. 'In California, which is the first market where we are operating, Latinos make up over 50% of the Medicaid population, yet they experience worse health outcomes and lower engagement than other Medicaid members because the system does not meet their needs from a language and cultural perspective.'
The community health workers at Zócalo Health, who are hired and trained locally, are familiar with the challenges their patients face. With this perspective, they can better help clients navigate the healthcare system, identify benefits they qualify for, and connect them with support for housing, food, transportation, and other essential services.
For Cardenas, access to healthcare is an essential pathway to empowerment. He recently joined me for a conversation about the community-based services that Zócalo Health provides and how they support the company's mission to shape a more equitable healthcare system.
Hunter Conrad: Please share a bit about why you established Zócalo and the services it provides. How do they accommodate some of the unique challenges that Latinos face in accessing healthcare services?
Erik Cárdenas: Zócalo Health was born out of both a personal and professional calling. Growing up in a predominantly Mexican neighborhood in Houston, I saw firsthand how Latino families struggle to access culturally responsive, affordable, and trustworthy healthcare. Too often, the system feels like an impenetrable maze, particularly for Latinos on Medicaid, who face language barriers, provider shortages, and a deep mistrust of institutions due to years of systemic neglect. Many don't know what benefits they qualify for or how to navigate the system. Others face social barriers like food insecurity, unstable housing, or a lack of transportation, all of which directly impact health.
Zócalo Health was created to remove these barriers and provide whole-person care that reflects how Latinos actually engage with healthcare — not how the system expects them to. Our model blends primary care, behavioral health, and community support services through bilingual, culturally competent providers and trusted promotoras de salud (community health workers) who guide members through every step of their care.
We also take a flexible approach to care delivery that includes extended hours for working families, proactive outreach, and virtual, in-home, and community-based options. By meeting people where they are, honoring their lived experiences, and eliminating friction points, we're not just delivering healthcare — we're creating a system that Latinos trust and feel ownership over.
HC: How does Zócalo help individuals access and navigate the healthcare system – helping to overcome language barriers and a lack of systematic trust?
EC: For many Latinos, healthcare isn't just inaccessible — it's alienating. The system is complex, bureaucratic, and historically unwelcoming, leaving people feeling dismissed, misunderstood, or afraid to engage at all.
At Zócalo, we bridge this gap by prioritizing trust, language accessibility, and cultural alignment. Our promotoras de salud, who are trusted members of the Latino community, help individuals understand their Medicaid benefits and enroll in services. They go beyond logistics to help address deeply ingrained cultural beliefs that shape how Latinos engage with healthcare. By embedding trust into every interaction, removing language barriers, and simplifying the process, Zócalo Health doesn't just connect Latinos to care — we rebuild confidence in the system itself.
HC: How does access to healthcare play out beyond these individuals — to their families, communities, the economy, and society as a whole?
EC: In Latino communities, familismo — the cultural emphasis on family — is central to how people live, work, and make decisions. When one family member struggles with a chronic condition, mental health challenge, or unaddressed medical need, it affects everyone. A parent managing uncontrolled diabetes without proper support, for example, may miss work frequently, be unable to care for their children, or experience financial strain from ER visits. A child with undiagnosed asthma might struggle in school, impacting their future opportunities. By ensuring that individuals — especially parents and caregivers — have access to preventive and ongoing care, we're not just improving their lives; we're creating a more stable, healthier environment for entire families.
Latinos are the backbone of many industries in the U.S., including agriculture, construction, service, and hospitality. Yet, these same workers often lack access to employer-sponsored healthcare, making Medicaid their primary — if not only — option. Without access to preventive care, minor health issues can escalate into major problems that take individuals out of the workforce, destabilizing families and the local economy.
While we are a venture-backed startup, we are deeply committed to social impact. We don't just deliver care; we invest in the very communities we serve. One of the most powerful ways we do this is by hiring and developing community health workers from the same neighborhoods where our patients live. This has impact on two critical fronts:
This workforce development approach is a sustainable model for economic empowerment. Rather than relying on external organizations to provide social services, we are building economic opportunity directly within the community, ensuring that wealth and expertise remain where they are needed most.
From a broader economic perspective, when individuals have stable employment, access to healthcare, and career growth opportunities, they are better positioned to support their families, contribute to local economies, and break cycles of poverty that have persisted for generations.
HC: How does Zócalo work with health plans to coordinate care and clinical services?
EC: Zócalo Health is redefining how healthcare is delivered to Latino communities, and a critical part of that mission is our partnerships with Medicaid health plans. While we started in California, where we provide Enhanced Care Management (ECM) and community support services, our model is scalable and replicable. We are actively expanding to other states because the challenges we address — low engagement, fragmented care, and unmet social needs — are not unique to California. Health plans across the country need solutions that effectively reach, engage, and care for underserved populations, and that is exactly what we do.
California is home to the largest Latino population in the U.S., and Medicaid plays a vital role in ensuring healthcare access for this community. Despite this, Latinos continue to face significant barriers to care. We provide a community-centered, tech-enabled model that goes beyond traditional clinical care. Our services include ECM for Medicaid members with complex medical and social needs. We also connect Medicaid patients with bilingual, culturally competent providers. By embedding trusted community relationships into our care model, we increase engagement, improve health outcomes, and lower the total cost of care — key priorities for our health plan partners.
HC: Describe how you've seen access to healthcare change people's lives.
EC: We see every day how trust in healthcare can mean the difference between fear and hope, isolation and engagement. For many Latinos, especially those navigating the uncertainty of immigration policies, fear has become a barrier to care. Patients tell us they avoid leaving their homes, even for basic needs, worried that seeking help could expose them to risks beyond their health.
One woman, a Medicaid recipient, had been living in self-imposed isolation, afraid to step outside. She had ignored her own medical needs for months, unsure where to turn. But through Zócalo, she found a safe space. Our promotoras de salud reached out, listened without judgment, and connected her to essential resources.
Her story is not unique. Forty percent of Medicaid recipients report receiving care from someone they don't trust. We believe healthcare must earn that trust first. No one prioritizes heart health if they're worried about keeping the lights on, and no one focuses on managing diabetes when they fear losing their home.
This is why Zócalo Health exists: to meet people where they are, listen first, and create a system they feel safe engaging with. Only when people feel safe can they truly take charge of their health.
Hunter Conrad is a Senior Associate on the Impact Investing team at the Sorenson Impact Institute, where she focuses on driving health equity through strategic investments. With a passion for creating positive social change, Conrad leverages her expertise in building and scaling products in startups to identify and support ventures that address systemic health disparities and improve outcomes for underserved communities. She holds a bachelor's degree in Environmental Health from UC Berkeley and an MBA from the University of Utah where she won the 2024 Kellogg-Morgan Stanely Sustainable Investing Challenge.
Erik Cárdenas is the co-founder and CEO of Zócalo Health, a tech-enabled, value-based care provider dedicated to serving entire Latino households facing complex health challenges and unmet social needs. Focused on Medicaid families in underserved communities, Zócalo Health delivers culturally aligned care by meeting individuals where they are, supported by multidisciplinary care teams centered around the effective use of community health workers. Prior to launching Zócalo Health, Cárdenas was a founding team member and senior leader at Amazon Care, where he played a crucial role in leading technical teams and significantly contributed to Amazon's COVID-19 response and global testing initiatives. His entrepreneurial spirit and expertise in health systems are also reflected in his leadership roles at Tenet Health and EverlyWell. Cárdenas earned his undergraduate degree from the University of the Incarnate Word in San Antonio, TX. In 2023, he was recognized by Modern Healthcare, Fierce Pharma, and Rock Health for his innovative contributions to healthcare.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
a day ago
- Newsweek
America's Drinking Water is Changing How Babies Are Being Born: Study
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Even low levels of arsenic in U.S. public drinking water may increase the risk of below average birth weight and other adverse birth outcomes, says a new national study led by researchers at Columbia University. The findings, drawn from nearly 14,000 pregnancies across 35 cohort sites participating in the National Institutes of Health's Environmental influences on Child Health Outcomes (ECHO) program, were published on the medical journal site JAMA Network earlier this week. "It is concerning, but what really stands out as major concern from this study is that no exposure level seems truly safe during pregnancy," Vasilis Vasiliou, chair and professor of environmental health sciences at Yale School of Public Health, told Newsweek. Newsweek has contacted the EPA via email for comment. Why It Matters The research addresses growing concerns about the adequacy of U.S. drinking water safety standards, particularly for vulnerable populations. The findings suggest that health risks may occur from exposure below levels currently considered safe by the Environmental Protection Agency's (EPA) arsenic limit that was determined in 2001. The study also said that low birth weight and preterm birth are "important predictors of infant mortality and morbidity across the life span," highlighting that low-level exposure to arsenic in drinking water could have prolonged and even fatal impacts. File photo: a young girl drinks some water from a bottle. File photo: a young girl drinks some water from a bottle. Nicolas Messyasz/Sipa via AP What To Know The study found that prenatal exposure to arsenic—even below the current federal standard of 10 micrograms per liter—was linked to a higher likelihood of babies being born preterm, with lower birth weights, or smaller than expected for their gestational age. Preterm birth was noted when a baby had a gestational age of less than 37 weeks, and low birth weight was identified as a weight of less than 2500 grams, or 2.5 kilograms. Both outcomes were observed across multiple racial and ethnic groups, including White, Black, Hispanic/Latino, American Indian, Alaska Native, Native Hawaiian, and Pacific Islander families. The authors noted that the risk of low birth weight following prenatal exposure to arsenic was higher among White, Black and Hispanic/Latino birthing parents. "Arsenic's toxicity during pregnancy is multifactorial, involving oxidative stress, epigenetic disruption, placental toxicity, immune dysregulation, and hormonal interference—all of which can independently or jointly lead to low birth weight, preterm birth, and developmental programming of chronic disease," Vasiliou told Newsweek. In 2001, the EPA announced its 10 micrograms per liter standard for arsenic. At the time, the EPA Administrator, Christine Todd Whitman, stated that "the 10 ppb protects public health based on the best available science and ensures that the cost of the standard is achievable." However, some states, such as New Jersey and New Hampshire, have since enacted stricter limits of 5 micrograms per liter. "Arsenic is released from rocks and soil into groundwater, which then feeds into municipal supplies," Vasiliou said. He added that regions like the Southwest, parts of New England, Minnesota, and Wisconsin "are known for elevated natural levels." Human activities like mining, agriculture, and industrial processes "can raise arsenic levels in nearby water systems," he said. What People Are Saying Vasilis Vasiliou, chair and professor of environmental health sciences at Yale School of Public Health, told Newsweek: "I believe that based on this, the EPA should consider lowering the maximum contaminant level below 10 µg/L. The authors explicitly recommend this as a way to help reduce low‑birth weight rates. More frequent testing of public water systems, especially in high‑risk locales, along with investment in treatment technologies, for example coagulation, adsorption, ion exchange, will be essential. Communities with elevated but sub-limit arsenic should be informed about risks, and pregnant people encouraged to use alternative water sources or filtration. I believe that we should continue monitoring birth outcomes in relationship to low-dose arsenic exposure and refine risk estimates across different demographics." He added: "Arsenic isn't the only chemical of concern in tap water; I can list PFAS, 2,4-dioxane and other emerging chemical contaminants. Therefore, pregnant people often face multiple low-level exposures. Even small reductions in one contaminant can yield meaningful health improvements when cumulative." What Happens Next The study's authors urged for further research to dissect the combined influence of arsenic and other social determinants of health. They also stressed the importance of reviewing legacy contaminants like arsenic and updating health-based water safety standards at both federal and state levels.
Yahoo
12-06-2025
- Yahoo
Maria Ansari, MD, FACC, named to Modern Healthcare's list of 50 Most Influential Clinical Executives
Co-CEO of The Permanente Federation and leader of multiple Permanente Medical Groups at Kaiser Permanente, recognized for advancing AI technology, improving care access, and advocating for value-based care measures OAKLAND, Calif., June 12, 2025 /PRNewswire/ -- Maria Ansari, MD, FACC, co-CEO of The Permanente Federation at Kaiser Permanente, has been named to Modern Healthcare's list of 50 Most Influential Clinical Executives for 2025. Dr. Ansari was recognized for her strategic leadership of the Permanente Medical Groups, supporting extensive deployment of AI listening technology, improving access to care, reducing health disparities, and advocating on Capitol Hill for value-based care. Modern Healthcare honors physicians and clinicians in executive roles for their exceptional achievements in driving innovation, improving outcomes, serving their communities, and demonstrating exemplary leadership both within and beyond their organizations. "This recognition honors the dedication of our Permanente physicians, clinicians, nurses, and staff who bring Permanente Medicine to life every day — delivering care that is compassionate, patient-centered, and seamlessly coordinated," said Dr. Ansari. "Physician leadership is key to earning our patients' trust and ensuring clinical autonomy, allowing us to make decisions in the best interests of those we serve. The result is high-quality, high-value care within an integrated system — improving lives and shaping the future of health care." Alongside Federation co-CEO Ramin Davidoff, MD, Dr. Ansari leads the Permanente Medical Groups, where more than 25,000 physicians deliver value-based care to 12.6 million Kaiser Permanente members in 8 states and the District of Columbia. Dr. Ansari is also CEO and executive director of The Permanente Medical Group (TPMG), president and CEO of the Mid-Atlantic Permanente Medical Group, and CEO of Northwest Permanente, three of the largest and most accomplished medical groups in the country. Kaiser Permanente is comprised of the Permanente Medical Groups and Kaiser Foundation Health Plans and Hospitals. Examples of Dr. Ansari's leadership in physician wellness, patient outcomes, care experience, and more include: Overseeing deployment of ambient AI listening technology to 25,000 Permanente physicians — an innovation that improves the patient experience and reduces clerical work and physician burnout. Improving access in adult and family medicine at TPMG by reducing appointment booking times by more than 33%. Reducing disparities in hypertension control between white and Black patients by 33% and in diabetes control between white and Latino patients by 25% at TPMG. Advocating for value-based care on Capitol Hill, including measures to support the physician pipeline, improve health care quality, health IT, and coordinated care. Advancing the highest quality specialty care. All 3 Northern California Kaiser Permanente cardiac surgery hubs — Sacramento, San Francisco, and Santa Clara — earned the Society of Thoracic Surgeons' highest quality rating for positive patient outcomes resulting from isolated coronary artery bypass graft procedures. Improving physician wellness. 6 Permanente Medical Groups have been recognized in the past 2 years by the American Medical Association's Joy in Medicine Award for their ongoing commitment to improve physician well-being and reducing burnout In addition to these achievements, Dr. Ansari oversees the Kaiser Permanente Division of Research (DOR), whose investigators, along with clinician-researchers, form one of the largest research facilities in the nation. Their work supports medical advancements by publishing close to 1,000 research papers annually. The DOR also launched the Augmented Intelligence in Medicine and Healthcare Initiative Coordinating Center to fund research projects that deploy AI and machine learning algorithms to enhance diagnostic decision-making. The complete list of honorees and their profiles are available at 50 Most Influential Clinical Executives – 2025 | Modern Healthcare and in the June 9 issue of Modern Healthcare magazine. A digital subscription is required to view the online profiles. To learn more about Permanente Medicine, visit About the Permanente Medical GroupsThe Permanente Medical Groups are self-governed, physician-led, prepaid, multispecialty medical groups composed of more than 25,000 physicians. We are dedicated to the mission of improving the health of our patients and communities. Together with the Kaiser Foundation Health Plans and Kaiser Foundation Hospitals, we are Kaiser Permanente — an award-winning health care system that delivers Permanente Medicine, care that is person- and family-centered, compassionate, evidence-based, technology-enabled, culturally responsive, team-delivered and physician-led, to 12.6 million Kaiser Permanente members. We work collaboratively, enabled by state-of-the art facilities and technology, to provide world-class preventive and complex care centered in eight states — from Hawaii to Maryland — and the District of Columbia. About The Permanente FederationThe Permanente Federation LLC is the national leadership and consulting organization for the Permanente Medical Groups, which, together with the Kaiser Foundation Health Plans and Kaiser Foundation Hospitals, comprise Kaiser Permanente. The Federation works on behalf of the Permanente Medical Groups to optimize care delivery and spread Permanente Medicine — care that is person- and family-centered, compassionate, evidence-based, technology-enabled, culturally responsive, team-delivered and physician-led. The Federation, based in Oakland, California, fosters an open learning environment and accelerates research, innovation, and performance improvements across the Permanente Medical Groups to expand the reach of Kaiser Permanente's integrated care delivery model and to lead the nation in transforming health care delivery. View original content to download multimedia: SOURCE The Permanente Federation
Yahoo
12-06-2025
- Yahoo
BioNTech to Acquire CureVac in Stock Deal Valued Around $1.25 Billion
BioNTech will acquire all shares of CureVac after the two sides reached an agreement in a deal valued around $1.25 billion. Each share of CureVac, a clinical-stage biotech company, will be exchanged for about $5.46 in BioNTech American depositary shares. Upon the deal's closing, CureVac shareholders are expected to own between 4% and 6% of the German developer of RNA vaccines and immunotherapies. ICE Raids Have Sent Latino Shoppers Into Hiding and Big Brands Are Hurting The Secret to Retaining the Best Employees: Ask Them These Four Questions Here's How Much Money the U.S. Is Earning From Tariffs, in Charts How Home Depot Became Ground Zero in Trump's Deportation Push Supply Chains Become New Battleground in the Global Trade War BioNTech Chief Executive Ugur Sahin said the plan is to bring complementary capabilities between the two companies together to develop transformative cancer treatments. CureVac's operating subsidiary will become a wholly owned subsidiary of BioNTech following the close of the transaction. As part of this plan, BioNTech will integrate CureVac's research and manufacturing site in Tübingen, Germany. The deal was unanimously approved by both companies' management and supervisory boards. It is expected to close in 2025. Shares of CureVac surged 29% to $5.25 in premarket trading. Write to Denny Jacob at Pulls Outlook as Sales Fall Bojangles Is Exploring a Sale While the Fried-Chicken Market Is Hot Why Bosses Should Give Feedback in the Morning The Audacious Reboot of America's Nuclear Energy Program Muted May Inflation Defies Tariff Fears Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
